查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1954662

胜肽合成市場規模、佔有率、成長及全球產業分析：依產品、方法、應用、最終用戶和地區劃分的洞察與預測（2026-2034）

Peptide Synthesis Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 220 Pages | 商品交期: 請詢問到貨日

價格

胜肽合成市場成長驅動因子

2025年全球胜肽合成市場規模達7.467億美元，預計2026年將成長至8.016億美元。預計2034年將達到16.4052億美元，預測期內年複合成長率高達9.39%。

北美在全球胜肽合成市場中佔據領先地位，2025年市場佔有率為48.59%。成長驅動因素包括對肽類藥物需求的不斷成長、合成技術的進步以及研發投入的增加。

胜肽合成是指利用化學或生物方法建構短胺基酸鏈的過程。特定序列。固相肽合成（SPPS）和液相肽合成（LPPS）等現代技術能夠實現客製化胜肽的生產，用於治療、診斷和研究應用。

市場動態

市場驅動因素

對胜肽類藥物的需求不斷增加

胜肽類藥物因其高特異性、低毒性和優於小分子藥物的安全性，其應用日益廣泛，這是推動市場成長的關鍵因素之一。肽類藥物廣泛應用於腫瘤學、代謝性疾病、糖尿病和罕見疾病等領域。

例如，2025年 8月，BioMed X 與Novo Nordisk合作開發胜肽類藥物的口服製劑，包括 GLP-1 受體促效劑。臨床試驗中胜肽類治療藥物的不斷增加，顯著推動了合成需求。

市場限制因子

大規模生產的技術限制因子

儘管胜肽合成市場成長強勁，但大規模胜肽合成仍面臨諸多挑戰，例如偶聯不完全、聚集、外消旋化以及溶劑消耗量高。將固相胜肽合成（SPPS）從實驗室規模擴大到商業化生產通常會導致純化成本增加和產率降低，阻礙市場擴張。

市場機會

合成方法的技術進步

微波輔助固相胜肽合成（SPPS）、混合固相胜肽合成-液相胜肽合成（SPPS-LPPS）技術、連續流合成等創新技術改變胜肽的生產效率。這些進步降低了溶劑用量，縮短了反應週期，並提高了產率和純度。

例如，2022年4月，CEM推出了 "Liberty Blue 2.0" 微波胜肽合成儀，溶劑用量減少了90%以上，實現了更環保的生產流程。

市場挑戰

生產和純化成本高

長鏈且結構複雜的胜肽需要多步驟合成，並透過高效液相層析（HPLC）進行純化，這顯著增加了成本。例如，由39個胺基酸組成的胜肽類藥物替澤帕肽（Mounjaro）需要大量的純化和複雜的生產過程，導致生產成本上升。

市場趨勢

擴大外包給CDMO

一個主要的市場趨勢是，越來越多的胜肽類生產外包給專業的合約研發生產力機構（CDMO）。製藥公司日益選擇外包，以減少基礎設施投資並加快產品上市速度。

2024年7月，Corden Pharma宣布投資9億歐元（10.472億美元）擴大其全球胜肽類產能，凸顯了外包需求的成長。

細分市場分析

依產品和服務劃分

市場分為產品和服務兩部分。

預計到2026年，服務部分將佔據市場主導地位，市場佔有率達到71.03%，這主要得益於外包業務的成長以及對大規模肽類生產需求的增加。2025年10月，Cambrex宣布投資1.2億美元擴大其在美國的胜肽生產產能。

依方法劃分

該市場包含以下方法：

  • 固相胜肽合成（SPPS）
  • 液相胜肽合成（LPPS）
  • 其他

預計到2026年，SPPS 方法將佔據 74.42%的市場佔有率，這主要得益於其自動化相容性、可擴展性和高效率。預計在預測期內，LPPS細分市場將以6.45%的年複合成長率成長。

依應用領域劃分

主要應用領域如下：

  • 治療藥物
  • 診斷
  • 研發

預計到2026年，治療藥物細分市場將佔據最大的市場佔有率，達到66.25%，這主要得益於胜肽類藥物商業化程度的提高和強大的臨床研發管線。預計在預測期內，診斷藥物細分市場將以7.35%的年複合成長率成長。

依最終使用者劃分

市場區隔如下：

  • 製藥和生技公司
  • CRO 和 CDMO
  • 學術和研究機構
  • 其他

在積極的治療創新和策略合作的支持下，製藥和生物技術公司預計將引領市場，在2025年佔據 57.1%的市場佔有率，在2026年佔據 56.94%的市場佔有率。 CRO 和 CDMO 細分市場預計將以 11.62%的年複合成長率成長。

區域展望

北美

北美引領市場，2025年市場規模為 3.6284億美元，2026年為 3.8908億美元。光是美國市場預計就將達到2026年，在強勁的生物製藥研發和策略合作的推動下，市場規模將達到3.6076億美元。

歐洲

2025年，歐洲市場規模達到1.601億美元，年複合成長率為8.72%。法國到2025年達到2,410萬美元，而英國和德國預計到2026年將分別達到3,974萬美元和3,584萬美元。

亞太地區

2025年，亞太地區市場規模達到1.404億美元。到2026年，日本預計將達到4,953萬美元，中國將達到3,001萬美元，印度將達到2,926萬美元。

拉丁美洲、中東和非洲

到2025年，拉丁美洲的市場規模達到 3,500萬美元，而GCC國家到2025年的市場規模達到 1,840萬美元。這些地區的成長得益於不斷擴大的研發活動。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 市場趨勢

第4章 主要考察

  • 胜肽合成技術發展
  • 主要國家的監管狀況
  • 主要產業趨勢（併購、合作等）
  • 主要公司新產品發布

第5章 全球胜肽合成市場分析、洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依產品分類
    • 產品
      • 設備
      • 試劑和耗材
    • 服務
      • 客製化研究級胜肽合成
      • 胜肽庫合成
      • 其他
  • 市場分析、洞察與預測：依方法分類
    • 溶液相胜肽合成
    • 固相胜肽合成
    • 其他
  • 市場分析、洞察與預測：依應用分類
    • 治療藥物
    • 診斷
    • 研發
  • 市場分析、洞察與預測：依應用分類 預測：依最終用戶劃分
    • 製藥和生技公司
    • 合約研究組織（CRO）與合約研發生產力組織（CDMO）
    • 學術和研究機構
    • 其他
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章 北美胜肽合成市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第7章 歐洲胜肽合成市場分析、洞察與預測（2021-2034）

  • 依國家/地區
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 北歐國家
    • 歐洲其他地區

第8章 亞太地區胜肽合成市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 東南亞
    • 亞太其他地區

第9章 拉丁美洲胜肽合成市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 其他地區拉丁美洲

第10章 中東與非洲胜肽合成市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • GCC國家
    • 南非
    • 中東和非洲其他地區

第11章 競爭分析

  • 全球市場佔有率分析（2025）
  • 公司簡介
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • GenScript
  • Agilent Technologies Inc.
  • Bachem AG
  • Waters Corporation
  • Danaher
  • PolyPeptide Group
  • Bio-Synthesis Inc.
  • CordenPharma
Product Code: FBI114373

Growth Factors of peptide synthesis Market

The global peptide synthesis market was valued at USD 746.7 million in 2025 and is projected to grow to USD 800.16 million in 2026. The market is further expected to reach USD 1,640.52 million by 2034, registering a strong CAGR of 9.39% during the forecast period.

North America dominated the global peptide synthesis market with a 48.59% market share in 2025. Growth is driven by rising demand for peptide-based therapeutics, technological advancements in synthesis techniques, and expanding research & development investments.

Peptide synthesis involves the chemical or biological construction of short amino acid chains in a defined sequence. Modern techniques such as solid-phase peptide synthesis (SPPS) and liquid-phase peptide synthesis (LPPS) enable customized peptide production for therapeutic, diagnostic, and research applications.

Market Dynamics

Market Drivers

Rising Demand for Peptide-Based Drugs

One of the primary growth drivers is the increasing adoption of peptide-based drugs due to their high specificity, low toxicity, and improved safety profiles compared to small-molecule drugs. Peptides are widely used in oncology, metabolic disorders, diabetes, and rare diseases.

For instance, in August 2025, BioMed X collaborated with Novo Nordisk to develop oral formulations for peptide drugs such as GLP-1 receptor agonists. The growing pipeline of peptide therapeutics in clinical trials is significantly driving synthesis demand.

Market Restraints

Technical Limitations in Large-Scale Production

Despite strong growth, large-scale peptide synthesis faces challenges including incomplete coupling, aggregation, racemization, and high solvent consumption. Scaling SPPS from laboratory to commercial production often results in increased purification costs and reduced yields, limiting broader market expansion.

Market Opportunities

Technological Advancements in Synthesis Methods

Innovations such as microwave-assisted SPPS, hybrid SPPS-LPPS techniques, and continuous-flow synthesis are transforming peptide production efficiency. These advancements reduce solvent usage, shorten cycle times, and improve yield and purity.

For example, in April 2022, CEM Corporation launched the Liberty Blue 2.0 microwave peptide synthesizer, reducing solvent use by over 90% and enabling greener production processes.

Market Challenges

High Production and Purification Costs

Long and structurally complex peptides require multi-step synthesis and high-performance liquid chromatography (HPLC) purification, significantly increasing costs. For example, tirzepatide (Mounjaro), a 39-amino acid peptide drug, requires large-scale purification and complex production processes, contributing to higher manufacturing expenses.

Market Trends

Growing Outsourcing to CDMOs

A key trend in the market is the increasing outsourcing of peptide manufacturing to specialized Contract Development and Manufacturing Organizations (CDMOs). Pharmaceutical companies prefer outsourcing to reduce infrastructure investment and accelerate time-to-market.

In July 2024, Corden Pharma announced a €900 million (USD 1,047.2 million) investment to expand global peptide production capacity, highlighting growing outsourcing demand.

Segmentation Analysis

By Offering

The market is divided into products and services.

The services segment dominated the market with a 71.03% share in 2026, driven by increased outsourcing and rising demand for large-scale peptide manufacturing. In October 2025, Cambrex Corporation announced a USD 120 million investment to expand peptide manufacturing capacity in the U.S.

By Method

The market includes:

  • Solid-Phase Peptide Synthesis (SPPS)
  • Liquid-Phase Peptide Synthesis (LPPS)
  • Others

The SPPS segment dominated with a 74.42% share in 2026, owing to automation compatibility, scalability, and high efficiency. The LPPS segment is expected to grow at a CAGR of 6.45% during the forecast period.

By Application

Applications include:

  • Therapeutics
  • Diagnostics
  • Research & Development

The therapeutics segment held the largest share at 66.25% in 2026, driven by increasing commercialization of peptide drugs and a strong clinical pipeline. Diagnostics is projected to grow at 7.35% during the forecast period.

By End User

The market is segmented into:

  • Pharmaceutical & Biotechnology Companies
  • CROs & CDMOs
  • Academic & Research Institutes
  • Others

Pharmaceutical & biotechnology companies dominated with a 57.1% share in 2025 and 56.94% in 2026, supported by active therapeutic innovation and strategic collaborations. The CROs & CDMOs segment is projected to grow at a CAGR of 11.62%.

Regional Outlook

North America

North America led the market with a valuation of USD 362.84 million in 2025 and is projected to reach USD 389.08 million in 2026. The U.S. market alone is expected to reach USD 360.76 million by 2026, driven by strong biopharmaceutical R&D and strategic collaborations.

Europe

Europe is projected to grow at a CAGR of 8.72% and recorded USD 160.1 million in 2025. France recorded USD 24.1 million in 2025, while the UK and Germany are projected to reach USD 39.74 million and USD 35.84 million respectively by 2026.

Asia Pacific

Asia Pacific reached USD 140.4 million in 2025. By 2026, Japan is projected to reach USD 49.53 million, China USD 30.01 million, and India USD 29.26 million.

Latin America & Middle East & Africa

Latin America recorded USD 35.0 million in 2025, while GCC countries reached USD 18.4 million in 2025. Growth in these regions is supported by expanding R&D activities.

Competitive Landscape

The market is semi-consolidated with key players including:

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Agilent Technologies Inc.
  • Bachem AG
  • PolyPeptide Group
  • Danaher

Strategic collaborations and technology upgrades strengthen competitive positioning. For instance, in May 2025, PeptiSystems partnered with Asahi Kasei Bioprocess America to enhance peptide synthesis technologies.

Conclusion

The global peptide synthesis market, valued at USD 746.7 million in 2025, is projected to grow to USD 800.16 million in 2026 and reach USD 1,640.52 million by 2034, expanding at a CAGR of 9.39%. Growth is primarily driven by rising demand for peptide-based therapeutics, technological advancements in SPPS and LPPS, and increasing outsourcing to CDMOs. Although high production costs and large-scale synthesis challenges remain, expanding R&D investments and innovative synthesis platforms are expected to sustain strong market growth through 2034.

Segmentation By Offering, Method, Application, End User, and Region

By Offering * Products

    • Instruments
      • Peptide Synthesizers
      • Lyophilizers
      • Chromatography Systems
      • Others
    • Reagents & Consumables
  • Services
    • Custom Research-Grade Peptide Synthesis
    • Peptide Library Synthesis
    • Others

By Method * Liquid-Phase Peptide Synthesis

  • Solid-Phase Peptide Synthesis
  • Others

By Application * Therapeutics

  • Diagnostics
  • Research & Development

By End User * Pharmaceutical & Biotechnology Companies

  • CROs & CDMOs
  • Academic & Research Institutes
  • Others

By Region * North America (By Offering, Method, Application, End User, and Country)

    • U.S.
    • Canada
  • Europe (By Offering, Method, Application, End User, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Offering, Method, Application, End User, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Offering, Method, Application, End User, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Offering, Method, Application, End User, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Technological Advancements in Peptide Synthesis
  • 4.2. Regulatory Scenario, By Key Countries/Regions
  • 4.3. Key Industry Developments (Mergers, Acquisitions, and Collaborations etc.)
  • 4.4. New Product Launches, By Key Players

5. Global Peptide Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Offering
    • 5.1.1. Products
      • 5.1.1.1. Instruments
        • 5.1.1.1.1. Peptide Synthesizers
        • 5.1.1.1.2. Lyophilizers
        • 5.1.1.1.3. Chromatography Systems
        • 5.1.1.1.4. Others
      • 5.1.1.2. Reagents & Consumables
    • 5.1.2. Services
      • 5.1.2.1. Custom Research-Grade Peptide Synthesis
      • 5.1.2.2. Peptide Library Synthesis
      • 5.1.2.3. Others
  • 5.2. Market Analysis, Insights and Forecast - By Method
    • 5.2.1. Liquid-Phase Peptide Synthesis
    • 5.2.2. Solid-Phase Peptide Synthesis
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. Therapeutics
    • 5.3.2. Diagnostics
    • 5.3.3. Research & Development
  • 5.4. Market Analysis, Insights and Forecast - By End User
    • 5.4.1. Pharmaceutical & Biotechnology Companies
    • 5.4.2. CROs & CDMOs
    • 5.4.3. Academic & Research Institutes
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Peptide Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Offering
    • 6.1.1. Products
      • 6.1.1.1. Instruments
        • 6.1.1.1.1. Peptide Synthesizers
        • 6.1.1.1.2. Lyophilizers
        • 6.1.1.1.3. Chromatography Systems
        • 6.1.1.1.4. Others
      • 6.1.1.2. Reagents & Consumables
    • 6.1.2. Services
      • 6.1.2.1. Custom Research-Grade Peptide Synthesis
      • 6.1.2.2. Peptide Library Synthesis
      • 6.1.2.3. Others
  • 6.2. Market Analysis, Insights and Forecast - By Method
    • 6.2.1. Liquid-Phase Peptide Synthesis
    • 6.2.2. Solid-Phase Peptide Synthesis
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. Therapeutics
    • 6.3.2. Diagnostics
    • 6.3.3. Research & Development
  • 6.4. Market Analysis, Insights and Forecast - By End User
    • 6.4.1. Pharmaceutical & Biotechnology Companies
    • 6.4.2. CROs & CDMOs
    • 6.4.3. Academic & Research Institutes
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Peptide Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Offering
    • 7.1.1. Products
      • 7.1.1.1. Instruments
        • 7.1.1.1.1. Peptide Synthesizers
        • 7.1.1.1.2. Lyophilizers
        • 7.1.1.1.3. Chromatography Systems
        • 7.1.1.1.4. Others
      • 7.1.1.2. Reagents & Consumables
    • 7.1.2. Services
      • 7.1.2.1. Custom Research-Grade Peptide Synthesis
      • 7.1.2.2. Peptide Library Synthesis
      • 7.1.2.3. Others
  • 7.2. Market Analysis, Insights and Forecast - By Method
    • 7.2.1. Liquid-Phase Peptide Synthesis
    • 7.2.2. Solid-Phase Peptide Synthesis
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. Therapeutics
    • 7.3.2. Diagnostics
    • 7.3.3. Research & Development
  • 7.4. Market Analysis, Insights and Forecast - By End User
    • 7.4.1. Pharmaceutical & Biotechnology Companies
    • 7.4.2. CROs & CDMOs
    • 7.4.3. Academic & Research Institutes
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Spain
    • 7.5.5. Italy
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Peptide Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Offering
    • 8.1.1. Products
      • 8.1.1.1. Instruments
        • 8.1.1.1.1. Peptide Synthesizers
        • 8.1.1.1.2. Lyophilizers
        • 8.1.1.1.3. Chromatography Systems
        • 8.1.1.1.4. Others
      • 8.1.1.2. Reagents & Consumables
    • 8.1.2. Services
      • 8.1.2.1. Custom Research-Grade Peptide Synthesis
      • 8.1.2.2. Peptide Library Synthesis
      • 8.1.2.3. Others
  • 8.2. Market Analysis, Insights and Forecast - By Method
    • 8.2.1. Liquid-Phase Peptide Synthesis
    • 8.2.2. Solid-Phase Peptide Synthesis
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. Therapeutics
    • 8.3.2. Diagnostics
    • 8.3.3. Research & Development
  • 8.4. Market Analysis, Insights and Forecast - By End User
    • 8.4.1. Pharmaceutical & Biotechnology Companies
    • 8.4.2. CROs & CDMOs
    • 8.4.3. Academic & Research Institutes
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. Japan
    • 8.5.2. China
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Peptide Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Offering
    • 9.1.1. Products
      • 9.1.1.1. Instruments
        • 9.1.1.1.1. Peptide Synthesizers
        • 9.1.1.1.2. Lyophilizers
        • 9.1.1.1.3. Chromatography Systems
        • 9.1.1.1.4. Others
      • 9.1.1.2. Reagents & Consumables
    • 9.1.2. Services
      • 9.1.2.1. Custom Research-Grade Peptide Synthesis
      • 9.1.2.2. Peptide Library Synthesis
      • 9.1.2.3. Others
  • 9.2. Market Analysis, Insights and Forecast - By Method
    • 9.2.1. Liquid-Phase Peptide Synthesis
    • 9.2.2. Solid-Phase Peptide Synthesis
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. Therapeutics
    • 9.3.2. Diagnostics
    • 9.3.3. Research & Development
  • 9.4. Market Analysis, Insights and Forecast - By End User
    • 9.4.1. Pharmaceutical & Biotechnology Companies
    • 9.4.2. CROs & CDMOs
    • 9.4.3. Academic & Research Institutes
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Peptide Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Offering
    • 10.1.1. Products
      • 10.1.1.1. Instruments
        • 10.1.1.1.1. Peptide Synthesizers
        • 10.1.1.1.2. Lyophilizers
        • 10.1.1.1.3. Chromatography Systems
        • 10.1.1.1.4. Others
      • 10.1.1.2. Reagents & Consumables
    • 10.1.2. Services
      • 10.1.2.1. Custom Research-Grade Peptide Synthesis
      • 10.1.2.2. Peptide Library Synthesis
      • 10.1.2.3. Others
  • 10.2. Market Analysis, Insights and Forecast - By Method
    • 10.2.1. Liquid-Phase Peptide Synthesis
    • 10.2.2. Solid-Phase Peptide Synthesis
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By Application
    • 10.3.1. Therapeutics
    • 10.3.2. Diagnostics
    • 10.3.3. Research & Development
  • 10.4. Market Analysis, Insights and Forecast - By End User
    • 10.4.1. Pharmaceutical & Biotechnology Companies
    • 10.4.2. CROs & CDMOs
    • 10.4.3. Academic & Research Institutes
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
    • 11.2.1. Thermo Fisher Scientific Inc.
    • 11.2.2. Merck KGaA
    • 11.2.3. GenScript
    • 11.2.4. Agilent Technologies Inc.
    • 11.2.5. Bachem AG
    • 11.2.6. Waters Corporation
    • 11.2.7. Danaher
    • 11.2.8. PolyPeptide Group
    • 11.2.9. Bio-Synthesis Inc.
    • 11.2.10. CordenPharma

List of Tables

  • Table 1: Global Peptide Synthesis Market Revenue (USD Million) Forecast, By Offering, 2021-2034
  • Table 2: Global Peptide Synthesis Market Revenue (USD Million) Forecast, By Products, 2021-2034
  • Table 3: Global Peptide Synthesis Market Revenue (USD Million) Forecast, By Instruments, 2021-2034
  • Table 4: Global Peptide Synthesis Market Revenue (USD Million) Forecast, By Services, 2021-2034
  • Table 5: Global Peptide Synthesis Market Revenue (USD Million) Forecast, By Method, 2021-2034
  • Table 6: Global Peptide Synthesis Market Revenue (USD Million) Forecast, By Application, 2021-2034
  • Table 7: Global Peptide Synthesis Market Revenue (USD Million) Forecast, By End User, 2021-2034
  • Table 8: Global Peptide Synthesis Market Revenue (USD Million) Forecast, By Region, 2021-2034
  • Table 9: North America Peptide Synthesis Market Revenue (USD Million) Forecast, By Offering, 2021-2034
  • Table 10: North America Peptide Synthesis Market Revenue (USD Million) Forecast, By Products, 2021-2034
  • Table 11: North America Peptide Synthesis Market Revenue (USD Million) Forecast, By Instruments, 2021-2034
  • Table 12: North America Peptide Synthesis Market Revenue (USD Million) Forecast, By Services, 2021-2034
  • Table 13: North America Peptide Synthesis Market Revenue (USD Million) Forecast, By Method, 2021-2034
  • Table 14: North America Peptide Synthesis Market Revenue (USD Million) Forecast, By Application, 2021-2034
  • Table 15: North America Peptide Synthesis Market Revenue (USD Million) Forecast, By End User, 2021-2034
  • Table 16: North America Peptide Synthesis Market Revenue (USD Million) Forecast, By Country, 2021-2034
  • Table 17: Europe Peptide Synthesis Market Revenue (USD Million) Forecast, By Offering, 2021-2034
  • Table 18: Europe Peptide Synthesis Market Revenue (USD Million) Forecast, By Products, 2021-2034
  • Table 19: Europe Peptide Synthesis Market Revenue (USD Million) Forecast, By Instruments, 2021-2034
  • Table 20: Europe Peptide Synthesis Market Revenue (USD Million) Forecast, By Services, 2021-2034
  • Table 21: Europe Peptide Synthesis Market Revenue (USD Million) Forecast, By Method, 2021-2034
  • Table 22: Europe Peptide Synthesis Market Revenue (USD Million) Forecast, By Application, 2021-2034
  • Table 23: Europe Peptide Synthesis Market Revenue (USD Million) Forecast, By End User, 2021-2034
  • Table 24: Europe Peptide Synthesis Market Revenue (USD Million) Forecast, By Country/Sub-Region, 2021-2034
  • Table 25: Asia Pacific Peptide Synthesis Market Revenue (USD Million) Forecast, By Offering, 2021-2034
  • Table 26: Asia Pacific Peptide Synthesis Market Revenue (USD Million) Forecast, By Products, 2021-2034
  • Table 27: Asia Pacific Peptide Synthesis Market Revenue (USD Million) Forecast, By Instruments, 2021-2034
  • Table 28: Asia Pacific Peptide Synthesis Market Revenue (USD Million) Forecast, By Services, 2021-2034
  • Table 29: Asia Pacific Peptide Synthesis Market Revenue (USD Million) Forecast, By Method, 2021-2034
  • Table 30: Asia Pacific Peptide Synthesis Market Revenue (USD Million) Forecast, By Application, 2021-2034
  • Table 31: Asia Pacific Peptide Synthesis Market Revenue (USD Million) Forecast, By End User, 2021-2034
  • Table 32: Asia Pacific Peptide Synthesis Market Revenue (USD Million) Forecast, By Country/Sub-Region, 2021-2034
  • Table 33: Latin America Peptide Synthesis Market Revenue (USD Million) Forecast, By Offering, 2021-2034
  • Table 34: Latin America Peptide Synthesis Market Revenue (USD Million) Forecast, By Products, 2021-2034
  • Table 35: Latin America Peptide Synthesis Market Revenue (USD Million) Forecast, By Instruments, 2021-2034
  • Table 36: Latin America Peptide Synthesis Market Revenue (USD Million) Forecast, By Services, 2021-2034
  • Table 37: Latin America Peptide Synthesis Market Revenue (USD Million) Forecast, By Method, 2021-2034
  • Table 38: Latin America Peptide Synthesis Market Revenue (USD Million) Forecast, By Application, 2021-2034
  • Table 39: Latin America Peptide Synthesis Market Revenue (USD Million) Forecast, By End User, 2021-2034
  • Table 40: Latin America Peptide Synthesis Market Revenue (USD Million) Forecast, By Country/Sub-Region, 2021-2034
  • Table 41: Middle East & Africa Peptide Synthesis Market Revenue (USD Million) Forecast, By Offering, 2021-2034
  • Table 42: Middle East & Africa Peptide Synthesis Market Revenue (USD Million) Forecast, By Products, 2021-2034
  • Table 43: Middle East & Africa Peptide Synthesis Market Revenue (USD Million) Forecast, By Instruments, 2021-2034
  • Table 44: Middle East & Africa Peptide Synthesis Market Revenue (USD Million) Forecast, By Services, 2021-2034
  • Table 45: Middle East & Africa Peptide Synthesis Market Revenue (USD Million) Forecast, By Method, 2021-2034
  • Table 46: Middle East & Africa Peptide Synthesis Market Revenue (USD Million) Forecast, By Application, 2021-2034
  • Table 47: Middle East & Africa Peptide Synthesis Market Revenue (USD Million) Forecast, By End User, 2021-2034
  • Table 48: Middle East & Africa Peptide Synthesis Market Revenue (USD Million) Forecast, By Country/Sub-Region, 2021-2034

List of Figures

  • Figure 1: Global Peptide Synthesis Market Revenue Breakdown (USD Million, %) By Region, 2025 & 2034
  • Figure 2: Global Peptide Synthesis Market Value Share (%), By Offering, 2025 & 2034
  • Figure 3: Global Peptide Synthesis Market Value Share (%), By Method, 2025 & 2034
  • Figure 4: Global Peptide Synthesis Market Value Share (%), By Application, 2025 & 2034
  • Figure 5: Global Peptide Synthesis Market Value Share (%), By End User, 2025 & 2034
  • Figure 6: Global Peptide Synthesis Market Value (USD Million), By Region, 2025 & 2034
  • Figure 7: North America Peptide Synthesis Market Value (USD Million), By Offering, 2025 & 2034
  • Figure 8: North America Peptide Synthesis Market Value Share (%), By Offering, 2025
  • Figure 9: North America Peptide Synthesis Market Value (USD Million), By Method, 2025 & 2034
  • Figure 10: North America Peptide Synthesis Market Value Share (%), By Method, 2025
  • Figure 11: North America Peptide Synthesis Market Value (USD Million), By Application, 2025 & 2034
  • Figure 12: North America Peptide Synthesis Market Value Share (%), By Application, 2025
  • Figure 13: North America Peptide Synthesis Market Value (USD Million), By End User, 2025 & 2034
  • Figure 14: North America Peptide Synthesis Market Value Share (%), By End User, 2025
  • Figure 15: North America Peptide Synthesis Market Value (USD Million), By Country, 2025 & 2034
  • Figure 16: North America Peptide Synthesis Market Value Share (%), By Country, 2025
  • Figure 17: Europe Peptide Synthesis Market Value (USD Million), By Offering, 2025 & 2034
  • Figure 18: Europe Peptide Synthesis Market Value Share (%), By Offering, 2025
  • Figure 19: Europe Peptide Synthesis Market Value (USD Million), By Method, 2025 & 2034
  • Figure 20: Europe Peptide Synthesis Market Value Share (%), By Method, 2025
  • Figure 21: Europe Peptide Synthesis Market Value (USD Million), By Application, 2025 & 2034
  • Figure 22: Europe Peptide Synthesis Market Value Share (%), By Application, 2025
  • Figure 23: Europe Peptide Synthesis Market Value (USD Million), By End User, 2025 & 2034
  • Figure 24: Europe Peptide Synthesis Market Value Share (%), By End User, 2025
  • Figure 25: Europe Peptide Synthesis Market Value (USD Million), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Peptide Synthesis Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Peptide Synthesis Market Value (USD Million), By Offering, 2025 & 2034
  • Figure 28: Asia Pacific Peptide Synthesis Market Value Share (%), By Offering, 2025
  • Figure 29: Asia Pacific Peptide Synthesis Market Value (USD Million), By Method, 2025 & 2034
  • Figure 30: Asia Pacific Peptide Synthesis Market Value Share (%), By Method, 2025
  • Figure 31: Asia Pacific Peptide Synthesis Market Value (USD Million), By Application, 2025 & 2034
  • Figure 32: Asia Pacific Peptide Synthesis Market Value Share (%), By Application, 2025
  • Figure 33: Asia Pacific Peptide Synthesis Market Value (USD Million), By End User, 2025 & 2034
  • Figure 34: Asia Pacific Peptide Synthesis Market Value Share (%), By End User, 2025
  • Figure 35: Asia Pacific Peptide Synthesis Market Value (USD Million), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Peptide Synthesis Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Peptide Synthesis Market Value (USD Million), By Offering, 2025 & 2034
  • Figure 38: Latin America Peptide Synthesis Market Value Share (%), By Offering, 2025
  • Figure 39: Latin America Peptide Synthesis Market Value (USD Million), By Method, 2025 & 2034
  • Figure 40: Latin America Peptide Synthesis Market Value Share (%), By Method, 2025
  • Figure 41: Latin America Peptide Synthesis Market Value (USD Million), By Application, 2025 & 2034
  • Figure 42: Latin America Peptide Synthesis Market Value Share (%), By Application, 2025
  • Figure 43: Latin America Peptide Synthesis Market Value (USD Million), By End User, 2025 & 2034
  • Figure 44: Latin America Peptide Synthesis Market Value Share (%), By End User, 2025
  • Figure 45: Latin America Peptide Synthesis Market Value (USD Million), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Peptide Synthesis Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Peptide Synthesis Market Value (USD Million), By Offering, 2025 & 2034
  • Figure 48: Middle East & Africa Peptide Synthesis Market Value Share (%), By Offering, 2025
  • Figure 49: Middle East & Africa Peptide Synthesis Market Value (USD Million), By Method, 2025 & 2034
  • Figure 50: Middle East & Africa Peptide Synthesis Market Value Share (%), By Method, 2025
  • Figure 51: Middle East & Africa Peptide Synthesis Market Value (USD Million), By Application, 2025 & 2034
  • Figure 52: Middle East & Africa Peptide Synthesis Market Value Share (%), By Application, 2025
  • Figure 53: Middle East & Africa Peptide Synthesis Market Value (USD Million), By End User, 2025 & 2034
  • Figure 54: Middle East & Africa Peptide Synthesis Market Value Share (%), By End User, 2025
  • Figure 55: Middle East & Africa Peptide Synthesis Market Value (USD Million), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Peptide Synthesis Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Peptide Synthesis Market Share (%), By Company, 2025